Tag: KalVista

KalVista CEO Benjamin Palleiko Sells Inventory Value $74,363 By Investing.com

CAMBRIDGE, Mass.—KalVista Prescription drugs, Inc. (NASDAQ:), a $463 million market cap biopharmaceutical…

Gossip247 Gossip247